Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
15,472,369
-
Share change
-
+15,472,369
-
Total reported value
-
$353,202,781
-
Price per share
-
$22.84
-
Number of holders
-
59
-
Value change
-
+$353,202,782
-
Number of buys
-
59
Institutional Holders of KALA BIO INC COM NEW - Stock (KALA) as of Q3 2017
As of 30 Sep 2017,
KALA BIO INC COM NEW - Stock (KALA) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,472,369 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, Polaris Venture Management Co. V, L.L.C., Vivo Capital, LLC, FMR LLC, CAXTON CORP, VICTORY CAPITAL MANAGEMENT INC, BlackRock Inc., and VANGUARD GROUP INC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.